Treatment of refractory rheumatoid arthritis with a chimeric ANTI‐CD4 monoclonal antibody
- 1 June 1994
- journal article
- case report
- Published by Wiley in Arthritis & Rheumatism
- Vol. 37 (6), 834-838
- https://doi.org/10.1002/art.1780370610
Abstract
Objective. To evaluate CD4+ T cell counts of rheumatoid arthritis (RA) patients at 18 and 30 months after treatment with a chimeric anti‐CD4 monoclonal antibody (MAb), cM‐T412, in a phase I trial. Methods. Of the 25 RA patients who received the MAb, 23 were available for followup at 18 and 30 months. Levels of circulating CD4+ T cells were measured by flow cytometry. Results. Circulating CD4+ T cell levels in these 23 RA patients remained below normal at 18 and 30 months posttreatment. More profound CD4+ T cell depletion was noted in the higher‐dose groups (300 and 700 mg). Conclusion. Prolonged suppression of circulating CD4+ T cells was noted both in single‐infusion and multiple‐infusion groups 18 and 30 months after cM‐T412 treatment. The depression was more pronounced in patients who received multiple infusions of cM‐T412. The prolonged decrease in CD4+ T cell numbers suggests that the capacity to reconstitute CD4+ T cells in this patient population (treated with methotrexate) is limited. One patient, who was also receiving methotrexate and prednisone, died 18 months after receiving 100 mg of cM‐T412. No other significant adverse effects, in particular, no opportunistic infections, were reported in these 23 RA patients at 18 and 30 months of followup.Keywords
This publication has 35 references indexed in Scilit:
- Use of a chimeric monoclonal anti‐CD4 antibody in patients with refractory rheumatoid arthritisArthritis & Rheumatism, 1993
- Effects of intravenous and oral dexamethasone on selected lymphocyte subpopulations in normal subjectsPsychoneuroendocrinology, 1992
- Acute and chronic suppression of leukotriene B4 synthesis EX vivo in neutrophils from patients with rheumatoid arthritis beginning treatment with methotrexateArthritis & Rheumatism, 1992
- Pneumocystis carinii Pneumonia Due to CorticosteroidsSouthern Medical Journal, 1992
- Pneumocystis carinii pneumonia as a complication of methotrexate treatment of asthma.Thorax, 1991
- Treatment of rheumatoid arthritis with monoclonal CD4 antibody M‐T151. Clinical results and immunopharmacologic effects in an open study, including repeated administrationArthritis & Rheumatism, 1991
- Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis.Thorax, 1991
- Treatment of rheumatoid arthritis with an anti‐CD4 monoclonal antibodyArthritis & Rheumatism, 1991
- Comparative effects on the immune system of methotrexate and trimetrexateInternational Journal of Immunopharmacology, 1987
- Pneumocystis carinii pneumonia following methotrexate therapy for rheumatoid arthritisArthritis & Rheumatism, 1983